Original paper
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade
Abstract
Low-dose targeted radionuclide therapy combined with immune checkpoint inhibition enhances complete response rates in preclinical tumor...
Paper Details
Title
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade
Published Date
Jul 14, 2021
Volume
13
Issue
602